Incyte has been granted a patent for salt forms of a Pim kinase inhibitor, which is useful in treating Pim kinase-related diseases, including cancer. The patent details methods of preparation and intermediates for this compound. GlobalData’s report on Incyte gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Incyte, Peptide pharmacophores was a key innovation area identified from patents. Incyte's grant share as of June 2024 was 36%. Grant share is based on the ratio of number of grants to total number of patents.
Pim kinase inhibitor salt forms for cancer treatment
The granted patent US12043614B2 encompasses claims related to an intermediate compound, which is a key component in various chemical processes or formulations. The claims specify that the intermediate compound can be selected from a defined group, although the specific details of the compounds are not disclosed in the provided text. Each claim builds upon the first, indicating that the intermediate compound can take on various forms or characteristics, which may be relevant for its application in different contexts.
The claims further elaborate on the versatility of the intermediate compound by suggesting that it can possess specific attributes or modifications, although these attributes are not detailed in the provided claims. This structure indicates a focus on the compound's adaptability and potential utility in various applications, which may include pharmaceuticals, materials science, or other chemical industries. The patent's claims highlight the importance of the intermediate compound in facilitating further developments or innovations in its respective field.
To know more about GlobalData’s detailed insights on Incyte, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
